Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-050312
Filing Date
2024-12-16
Accepted
2024-12-16 21:51:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7268
2 ex1.htm EX-1 8473
  Complete submission text file 0001493152-24-050312.txt   17463
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Subject) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89510 | Film No.: 241553484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 212-256-8600
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

EIN.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G